On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


ChineseInvestors.com, Inc. (CIIX) Participates In SeeThruEquity Microcap Investor Conference, Receives Research Report Confidence in its Cannabis Market Penetration and Growth

ChineseInvestors.com, Inc. (OTCQB: CIIX) participated in SeeThruEquity’s 6th Annual Microcap Investor Conference on June 1, 2017, in New York. That conference gives investors the exclusive opportunity to discover publicly traded companies with market capitalization of less than $1 billion.

CIIX offers educational consulting services for Chinese investors. Most recently, it has been pursuing opportunities in the cannabis market. The goal of the company is to be a leading publicly-traded company within the nutritional industry. In addition to its online store based in the free trade zone of Shanghai, China, CIIX is building its first retail store in San Gabriel, California. There, it will sell primarily hemp oil-based products. The company is based in San Gabriel, California.

“SeeThruEquity gave CIIX a price target of $2.05 one year ago,” Warren Wang, founder and CEO of CIIX, noted in a news release. “Recently, the firm increased CIIX’s price target to $3.75, reflecting huge growth potential based on our legal medical cannabis initiatives. In addition, SeeThruEquity also gave CIIX a forecast for revenue from its hemp business projecting the revenue could grow from $0.7 million in FY2017 to reach 8-digit sales by FY2020E, with continued growth thereafter.”

SeeThruEquity (http://dtn.fm/HC0yY) increased the price target on CIIX based on the potential for the company’s legal cannabis initiatives. These include CIIX’s early stage efforts to penetrate the market and the research company’s belief that CIIX can capitalize on its approach to broad cannabis industry growth.

“We view CIIX as a high-risk/high-reward investment opportunity in the microcap space, with potential of upside if the company can generate renewed traction with its high margin investor relations services business and execute on the new cannabis initiatives,” the report said.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

From Our Blog

“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”

April 24, 2024

In recent developments, PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, has taken swift action to address a pressing medical situation unfolding in Malawi, East Africa. The Ministry of Health (“MOH”) of Malawi has issued a plea for access to IV suramin, a vital medication in combating the life-threatening sleeping […]

Rotate your device 90° to view site.